MLKL deficiency protects against low-grade, sterile inflammation in aged mice

Cell Death Differ. 2023 Apr;30(4):1059-1071. doi: 10.1038/s41418-023-01121-4. Epub 2023 Feb 8.

Abstract

MLKL and RIPK3 are the core signaling proteins of the inflammatory cell death pathway, necroptosis, which is a known mediator and modifier of human disease. Necroptosis has been implicated in the progression of disease in almost every physiological system and recent reports suggest a role for necroptosis in aging. Here, we present the first comprehensive analysis of age-related histopathological and immunological phenotypes in a cohort of Mlkl-/- and Ripk3-/- mice on a congenic C57BL/6 J genetic background. We show that genetic deletion of Mlkl in female mice interrupts immune system aging, specifically delaying the age-related reduction of circulating lymphocytes. -Seventeen-month-old Mlkl-/- female mice were also protected against age-related chronic sterile inflammation in connective tissue and skeletal muscle relative to wild-type littermate controls, exhibiting a reduced number of immune cell infiltrates in these sites and fewer regenerating myocytes. These observations implicate MLKL in age-related sterile inflammation, suggesting a possible application for long-term anti-necroptotic therapy in humans.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Death
  • Female
  • Humans
  • Infant
  • Inflammation* / pathology
  • Mice
  • Mice, Inbred C57BL
  • Necrosis / metabolism
  • Protein Kinases* / metabolism
  • Receptor-Interacting Protein Serine-Threonine Kinases / metabolism
  • Transcription Factors / metabolism

Substances

  • Protein Kinases
  • Transcription Factors
  • Receptor-Interacting Protein Serine-Threonine Kinases
  • MLKL protein, human
  • MLKL protein, mouse